OA
BRLI

OFI Advisors’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

OFI Advisors’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-12,507
Closed -$516K – 1734
2015
Q2 		$516K Sell
12,507
-1,048
-8% -$37.6K 0.03% 725
2015
Q1 		$478K Buy
13,555
+147
+1% +$4.97K 0.03% 754
2014
Q4 		$431K Buy
13,408
+1,099
+9% +$31.8K 0.03% 771
2014
Q3 		$345K Buy
12,309
+641
+5% +$19.5K 0.02% 858
2014
Q2 		$353K Buy
11,668
+162
+1% +$4.47K 0.03% 855
2014
Q1 		$318K Buy
11,506
+958
+9% +$25.1K 0.02% 857
2013
Q4 		$269K Buy
10,548
+2,877
+38% +$88.7K 0.02% 933
2013
Q3 		$229K Buy
7,671
+1,412
+23% +$39.3K 0.02% 893
2013
Q2 		$180K Buy
+6,259
New +$172K 0.02% 941

Other funds holding BRLI

SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

OFI Advisors's BRLI Position: Q3 2015 in Review

OFI Advisors sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 12,507 shares — an estimated $516K sold.

OFI Advisors first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $516K in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

  • OFI Advisors reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
  • OFI Advisors sold 12,507 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $516K.
  • OFI Advisors first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
  • OFI Advisors's BIO-REFERENCE LABS INC-NEW- position peaked at $516K in Q2 2015.
  • 1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on OFI Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.